Antineutrophil cytoplasmic autoantibodies in systemic sclerosis with renal failure.
Huong Dl, H Beaufils, T. Papo(Assistance Publique – Hôpitaux de Paris), P Godeau(Normandie Université), C. Françès(Navarre Institute of Health Research), M. Gatfossé(Sorbonne Université)
PubMed
April 1, 1995
Cited by 8
Related Papers
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Skin Thickness Changes in Normal Aging Skin
|Gerontology|2009|258
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients
|Annals of the Rheumatic Diseases|2007|235
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207